These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
13-3711155
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large Accelerated filer
o
|
|
Accelerated filer
x
|
|
|
|
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
(Do not check if a smaller reporting company)
|
|
|
|
Emerging growth company
o
|
|
|
|
|
|
FORMFACTOR, INC.
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED APRIL 1, 2017
INDEX
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
FORMFACTOR, INC.
(In thousands, except per share amounts)
(Unaudited)
|
|||||||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
Revenues
|
$
|
128,829
|
|
|
$
|
53,611
|
|
|
Cost of revenues
|
81,258
|
|
|
43,819
|
|
||
|
Gross profit
|
47,571
|
|
|
9,792
|
|
||
|
Operating expenses:
|
|
|
|
|
|
||
|
Research and development
|
17,414
|
|
|
10,849
|
|
||
|
Selling, general and administrative
|
22,829
|
|
|
12,516
|
|
||
|
Restructuring and impairment charges, net
|
269
|
|
|
—
|
|
||
|
Total operating expenses
|
40,512
|
|
|
23,365
|
|
||
|
Operating income (loss)
|
7,059
|
|
|
(13,573
|
)
|
||
|
Interest income, net
|
67
|
|
|
117
|
|
||
|
Other income (expense), net
|
(1,574
|
)
|
|
(314
|
)
|
||
|
Income (loss) before income taxes
|
5,552
|
|
|
(13,770
|
)
|
||
|
Provision for income taxes
|
367
|
|
|
30
|
|
||
|
Net income (loss)
|
$
|
5,185
|
|
|
$
|
(13,800
|
)
|
|
Net income (loss) per share:
|
|
|
|
|
|
||
|
Basic
|
$
|
0.07
|
|
|
$
|
(0.24
|
)
|
|
Diluted
|
$
|
0.07
|
|
|
$
|
(0.24
|
)
|
|
Weighted-average number of shares used in per share calculations:
|
|
|
|
|
|
||
|
Basic
|
71,423
|
|
|
58,431
|
|
||
|
Diluted
|
72,922
|
|
|
58,431
|
|
||
|
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited)
|
|||||||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
Net income (loss)
|
$
|
5,185
|
|
|
$
|
(13,800
|
)
|
|
Other comprehensive income, net of tax:
|
|
|
|
||||
|
Foreign currency translation adjustments
|
1,447
|
|
|
603
|
|
||
|
Unrealized gains on available-for-sale marketable securities
|
—
|
|
|
38
|
|
||
|
Unrealized gains on derivative instruments
|
157
|
|
|
—
|
|
||
|
Other comprehensive income, net of tax
|
1,604
|
|
|
641
|
|
||
|
Comprehensive income (loss)
|
$
|
6,789
|
|
|
$
|
(13,159
|
)
|
|
FORMFACTOR, INC.
(In thousands, except share and per share amounts)
(Unaudited)
|
|||||||
|
|
April 1,
2017 |
|
December 31,
2016 |
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
114,437
|
|
|
$
|
101,408
|
|
|
Marketable securities
|
7,497
|
|
|
7,497
|
|
||
|
Accounts receivable, net
|
79,439
|
|
|
70,225
|
|
||
|
Inventories, net
|
60,371
|
|
|
59,806
|
|
||
|
Restricted cash
|
4
|
|
|
106
|
|
||
|
Refundable income taxes
|
1,105
|
|
|
1,391
|
|
||
|
Prepaid expenses and other current assets
|
11,348
|
|
|
14,276
|
|
||
|
Total current assets
|
274,201
|
|
|
254,709
|
|
||
|
Restricted cash
|
1,116
|
|
|
1,082
|
|
||
|
Property, plant and equipment, net
|
45,153
|
|
|
42,663
|
|
||
|
Goodwill
|
188,185
|
|
|
188,010
|
|
||
|
Intangibles, net
|
118,444
|
|
|
126,608
|
|
||
|
Deferred tax assets
|
3,322
|
|
|
3,310
|
|
||
|
Other assets
|
2,246
|
|
|
2,600
|
|
||
|
Total assets
|
$
|
632,667
|
|
|
$
|
618,982
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
$
|
43,316
|
|
|
$
|
34,075
|
|
|
Accrued liabilities
|
26,292
|
|
|
30,184
|
|
||
|
Current portion of term loan
|
14,601
|
|
|
12,701
|
|
||
|
Income taxes payable
|
50
|
|
|
442
|
|
||
|
Deferred revenue
|
6,590
|
|
|
5,305
|
|
||
|
Total current liabilities
|
90,849
|
|
|
82,707
|
|
||
|
Long-term income taxes payable
|
1,290
|
|
|
1,315
|
|
||
|
Term loan, less current portion
|
116,872
|
|
|
125,475
|
|
||
|
Deferred tax liabilities
|
3,770
|
|
|
3,703
|
|
||
|
Deferred rent and other liabilities
|
4,536
|
|
|
4,726
|
|
||
|
Total liabilities
|
217,317
|
|
|
217,926
|
|
||
|
Commitments and contingencies (Note 12)
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
|
|||
|
Preferred stock, $0.001 par value:
|
|
|
|
|
|||
|
10,000,000 shares authorized; no shares issued and outstanding at April 1, 2017 and December 31, 2016, respectively
|
—
|
|
|
—
|
|
||
|
Common stock, $0.001 par value:
|
|
|
|
|
|
||
|
250,000,000 shares authorized; 71,672,152 and 70,907,847 shares issued and outstanding at April 1, 2017 and December 31, 2016, respectively
|
72
|
|
|
71
|
|
||
|
Additional paid-in capital
|
840,714
|
|
|
833,341
|
|
||
|
Accumulated other comprehensive loss
|
(2,135
|
)
|
|
(3,740
|
)
|
||
|
Accumulated deficit
|
(423,301
|
)
|
|
(428,616
|
)
|
||
|
Total stockholders’ equity
|
415,350
|
|
|
401,056
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
632,667
|
|
|
$
|
618,982
|
|
|
FORMFACTOR, INC.
(In thousands)
(Unaudited)
|
|||||||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||
|
Net income (loss)
|
$
|
5,185
|
|
|
$
|
(13,800
|
)
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
|
Depreciation
|
3,162
|
|
|
2,468
|
|
||
|
Amortization
|
8,349
|
|
|
2,771
|
|
||
|
Accretion of discount on investments
|
—
|
|
|
(16
|
)
|
||
|
Stock-based compensation expense
|
3,302
|
|
|
2,734
|
|
||
|
Amortization of debt issuance costs
|
171
|
|
|
—
|
|
||
|
Deferred income tax provision
|
81
|
|
|
—
|
|
||
|
Recovery of doubtful accounts receivable
|
—
|
|
|
(34
|
)
|
||
|
Provision for excess and obsolete inventories
|
2,797
|
|
|
1,989
|
|
||
|
Acquired inventory step-up amortization
|
190
|
|
|
—
|
|
||
|
Loss on sale of long-lived assets
|
22
|
|
|
—
|
|
||
|
Gain on derivative instruments
|
(65
|
)
|
|
—
|
|
||
|
Foreign currency transaction gains
|
(729
|
)
|
|
(1,393
|
)
|
||
|
Changes in assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
(8,888
|
)
|
|
1,260
|
|
||
|
Inventories
|
(3,345
|
)
|
|
(5,750
|
)
|
||
|
Prepaid expenses and other current assets
|
3,068
|
|
|
2,108
|
|
||
|
Refundable income taxes
|
286
|
|
|
—
|
|
||
|
Other assets
|
615
|
|
|
(286
|
)
|
||
|
Accounts payable
|
7,220
|
|
|
8,824
|
|
||
|
Accrued liabilities
|
(4,780
|
)
|
|
(3,597
|
)
|
||
|
Income tax payable
|
(419
|
)
|
|
(2
|
)
|
||
|
Deferred rent and other liabilities
|
71
|
|
|
178
|
|
||
|
Deferred revenues
|
1,510
|
|
|
(486
|
)
|
||
|
Net cash provided by (used in) operating activities
|
17,803
|
|
|
(3,032
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Acquisition of property, plant and equipment
|
(3,465
|
)
|
|
(1,111
|
)
|
||
|
Proceeds from sale of subsidiary
|
14
|
|
|
9
|
|
||
|
Purchases of marketable securities
|
—
|
|
|
(6,591
|
)
|
||
|
Proceeds from maturities of marketable securities
|
—
|
|
|
12,700
|
|
||
|
Change in restricted cash
|
121
|
|
|
—
|
|
||
|
Net cash (used in) provided by investing activities
|
(3,330
|
)
|
|
5,007
|
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Proceeds from issuances of common stock
|
7,437
|
|
|
1,961
|
|
||
|
Purchase and retirement of common stock
|
(2,733
|
)
|
|
—
|
|
||
|
Tax withholdings related to net share settlements of equity awards
|
(480
|
)
|
|
—
|
|
||
|
Payments on term loan debt
|
(6,875
|
)
|
|
—
|
|
||
|
Net cash (used in) provided by financing activities
|
(2,651
|
)
|
|
1,961
|
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
1,207
|
|
|
1,713
|
|
||
|
Net increase in cash and cash equivalents
|
13,029
|
|
|
5,649
|
|
||
|
Cash and cash equivalents, beginning of period
|
101,408
|
|
|
146,264
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
114,437
|
|
|
$
|
151,913
|
|
|
|
|
|
|
||||
|
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|||||||
|
Non-cash investing and financing activities:
|
|
|
|
|
|
||
|
Changes in accounts payable and accrued liabilities related to property, plant and equipment purchases
|
$
|
2,035
|
|
|
$
|
1,166
|
|
|
|
|
|
|
||||
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Income and property taxes paid, net
|
$
|
407
|
|
|
$
|
22
|
|
|
|
Three Months Ended
|
||||
|
|
April 1, 2017
|
|
March 26, 2016
|
||
|
Intel
|
26.7
|
%
|
|
34.3
|
%
|
|
Samsung
|
10.3
|
|
|
10.4
|
|
|
Total revenues attributable to customers greater than 10%
|
37.0
|
%
|
|
44.7
|
%
|
|
|
|
Amount
|
||
|
Cash and cash equivalents
|
|
$
|
40,681
|
|
|
Accounts receivable
|
|
27,112
|
|
|
|
Inventory
|
|
38,315
|
|
|
|
Prepaid expenses and other current assets
|
|
6,249
|
|
|
|
Property, plant and equipment
|
|
19,875
|
|
|
|
Other long-term assets
|
|
818
|
|
|
|
Deferred revenue
|
|
(1,829
|
)
|
|
|
Accounts payable and accrued liabilities
|
|
(23,370
|
)
|
|
|
Deferred tax liabilities
|
|
(48,993
|
)
|
|
|
Other long-term liabilities
|
|
(960
|
)
|
|
|
Total tangible assets acquired and liabilities assumed
|
|
57,898
|
|
|
|
Intangible assets
|
|
149,753
|
|
|
|
Goodwill
|
|
158,141
|
|
|
|
Total acquisition price
|
|
$
|
365,792
|
|
|
|
|
Probe Cards
|
|
Systems
|
|
Total
|
||||||
|
|
|
(in thousands)
|
||||||||||
|
Goodwill, gross, as of December 31, 2016
|
|
$
|
172,482
|
|
|
$
|
15,528
|
|
|
$
|
188,010
|
|
|
Foreign currency translation
|
|
—
|
|
|
175
|
|
|
175
|
|
|||
|
Balance as of April 1, 2017
|
|
$
|
172,482
|
|
|
$
|
15,703
|
|
|
$
|
188,185
|
|
|
|
|
April 1, 2017
|
|
December 31, 2016
|
|
Weighted Average Useful Life (in years)
|
||||||||||||||||||||
|
Other Intangible Assets
|
|
Gross
|
|
Accumulated Amortization
|
|
Net
|
|
Gross
|
|
Accumulated Amortization
|
|
Net
|
|
April 1, 2017
|
||||||||||||
|
Existing developed technologies
|
|
$
|
142,824
|
|
|
$
|
61,258
|
|
|
$
|
81,566
|
|
|
$
|
142,701
|
|
|
$
|
56,131
|
|
|
$
|
86,570
|
|
|
4.1
|
|
Trade name
|
|
11,934
|
|
|
3,668
|
|
|
8,266
|
|
|
11,921
|
|
|
2,989
|
|
|
8,932
|
|
|
3.8
|
||||||
|
Customer relationships
|
|
39,908
|
|
|
12,200
|
|
|
27,708
|
|
|
39,869
|
|
|
10,854
|
|
|
29,015
|
|
|
5.5
|
||||||
|
Backlog
|
|
15,590
|
|
|
14,686
|
|
|
904
|
|
|
15,581
|
|
|
13,489
|
|
|
2,092
|
|
|
0.0
|
||||||
|
Total intangible assets
|
|
$
|
210,256
|
|
|
$
|
91,812
|
|
|
$
|
118,444
|
|
|
$
|
210,072
|
|
|
$
|
83,463
|
|
|
$
|
126,609
|
|
|
|
|
Fiscal Year
|
|
Amount
|
||
|
2017
|
|
$
|
22,366
|
|
|
2018
|
|
28,339
|
|
|
|
2019
|
|
25,675
|
|
|
|
2020
|
|
23,605
|
|
|
|
2021
|
|
12,937
|
|
|
|
and thereafter
|
|
5,522
|
|
|
|
Total
|
|
$
|
118,444
|
|
|
|
April 1, 2017
|
||
|
Senior secured term loan
|
$
|
132,500
|
|
|
Debt issuance costs
|
(1,027
|
)
|
|
|
Total debt less debt issuance costs
|
$
|
131,473
|
|
|
|
Employee Severance and Benefits
|
|
Contract Termination and Other Costs
|
|
Total
|
||||||
|
Accrual at December 31, 2016
|
$
|
330
|
|
|
$
|
104
|
|
|
$
|
434
|
|
|
Restructuring charges
|
248
|
|
|
21
|
|
|
269
|
|
|||
|
Cash payments
|
(423
|
)
|
|
(35
|
)
|
|
(458
|
)
|
|||
|
Adjustment to restructuring charges
|
32
|
|
|
—
|
|
|
32
|
|
|||
|
Accrual at April 1, 2017
|
$
|
187
|
|
|
$
|
90
|
|
|
$
|
277
|
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Cash equivalents
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
19,388
|
|
|
$
|
—
|
|
|
$
|
19,388
|
|
|
Marketable securities
|
|
|
|
|
|
||||||
|
U.S. Treasuries
|
—
|
|
|
7,497
|
|
|
7,497
|
|
|||
|
Interest rate swap derivative contracts
|
—
|
|
|
1,009
|
|
|
1,009
|
|
|||
|
Total assets
|
$
|
19,388
|
|
|
$
|
8,506
|
|
|
$
|
27,894
|
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Cash equivalents
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
19,350
|
|
|
$
|
—
|
|
|
$
|
19,350
|
|
|
Marketable securities
|
|
|
|
|
|
||||||
|
U.S. Treasuries
|
—
|
|
|
7,497
|
|
|
7,497
|
|
|||
|
Foreign exchange derivative contracts
|
—
|
|
|
1,137
|
|
|
1,137
|
|
|||
|
Interest rate swap derivative contracts
|
—
|
|
|
838
|
|
|
838
|
|
|||
|
Total
|
$
|
19,350
|
|
|
$
|
9,472
|
|
|
$
|
28,822
|
|
|
|
|
|
|
Amount of Loss Recognized on Derivatives
|
||||||
|
|
|
|
|
Three Months Ended
|
||||||
|
Derivatives Not Designated as Hedging Instruments
|
|
Location of Loss Recognized on Derivatives
|
|
April 1, 2017
|
|
March 26, 2016
|
||||
|
Foreign exchange forward contracts
|
|
Other income (expense), net
|
|
$
|
(886
|
)
|
|
$
|
(1,562
|
)
|
|
The Effect of Derivative Instruments on the Statement of Financial Performance
|
|||||||||||||||||||||||
|
For the Three Months Ended
|
|||||||||||||||||||||||
|
|
|
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)
|
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
|
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
|
Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion )
|
Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion )
|
|||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Derivatives in ASC 815 Cash Flow Hedging Relationships
|
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||
|
|
April 1, 2017
|
March 26, 2016
|
|
April 1, 2017
|
March 26, 2016
|
|
April 1, 2017
|
March 26, 2016
|
|||||||||||||||
|
Interest rate contracts
|
|
$
|
120
|
|
$
|
—
|
|
Other income (expense), net
|
|
$
|
(37
|
)
|
$
|
—
|
|
Other income (expense), net
|
|
$
|
14
|
|
$
|
—
|
|
|
Total
|
|
$
|
120
|
|
$
|
—
|
|
|
|
$
|
(37
|
)
|
$
|
—
|
|
|
|
$
|
14
|
|
$
|
—
|
|
|
|
April 1,
2017 |
|
December 31,
2016 |
||||
|
Raw materials
|
$
|
29,009
|
|
|
$
|
27,402
|
|
|
Work-in-progress
|
19,625
|
|
|
20,390
|
|
||
|
Finished goods
|
11,737
|
|
|
12,014
|
|
||
|
|
$
|
60,371
|
|
|
$
|
59,806
|
|
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
Balance at beginning of period
|
$
|
2,972
|
|
|
$
|
1,116
|
|
|
Accruals
|
1,127
|
|
|
805
|
|
||
|
Settlements
|
(1,517
|
)
|
|
(747
|
)
|
||
|
Balance at the end of period
|
$
|
2,582
|
|
|
$
|
1,174
|
|
|
|
Units
|
|
Weighted Average Grant Date Fair Value
|
|||
|
Restricted stock units at December 31, 2016
|
3,108,560
|
|
|
$
|
8.61
|
|
|
Awards granted
|
23,622
|
|
|
12.70
|
|
|
|
Awards vested
|
(94,608
|
)
|
|
3.51
|
|
|
|
Awards canceled
|
(102,721
|
)
|
|
8.70
|
|
|
|
Restricted stock units at April 1, 2017
|
2,934,853
|
|
|
$
|
8.81
|
|
|
|
|
Options Outstanding
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Life in Years
|
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at December 31, 2016
|
|
2,198,031
|
|
|
$
|
9.13
|
|
|
|
|
|
||
|
Options exercised
|
|
(560,950
|
)
|
|
8.09
|
|
|
|
|
|
|||
|
Outstanding at April 1, 2017
|
|
1,637,081
|
|
$
|
9.48
|
|
|
2.23
|
|
$
|
4,073,803
|
|
|
|
Vested and expected to vest at April 1, 2017
|
|
1,637,081
|
|
|
$
|
9.48
|
|
|
2.23
|
|
$
|
4,073,803
|
|
|
Exercisable at April 1, 2017
|
|
1,355,147
|
|
|
$
|
9.84
|
|
|
1.58
|
|
$
|
2,915,206
|
|
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
|
|
|
|
|
|
||
|
Cost of revenues
|
$
|
854
|
|
|
$
|
633
|
|
|
Research and development
|
1,082
|
|
|
796
|
|
||
|
Selling, general and administrative
|
1,366
|
|
|
1,305
|
|
||
|
Total stock-based compensation
|
$
|
3,302
|
|
|
$
|
2,734
|
|
|
|
Unrecognized Expense
|
|
Average Expected Recognition Period in Years
|
||
|
Stock options
|
$
|
932
|
|
|
1.81
|
|
Restricted stock units
|
17,328
|
|
|
2.04
|
|
|
Employee stock purchase plan
|
687
|
|
|
0.33
|
|
|
Total unrecognized stock-based compensation expense
|
$
|
18,947
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
Numerator:
|
|
|
|
|
|
||
|
Net income (loss) used in computing basic and diluted net income per share
|
$
|
5,185
|
|
|
$
|
(13,800
|
)
|
|
Denominator:
|
|
|
|
||||
|
Weighted-average shares used in computing basic net income (loss) per share
|
71,423
|
|
|
58,431
|
|
||
|
Add potentially dilutive securities
|
1,499
|
|
|
—
|
|
||
|
Weighted-average shares used in computing basic and diluted net income (loss) per share
|
72,922
|
|
|
58,431
|
|
||
|
Securities not included as they would have been antidilutive
|
126
|
|
|
4,257
|
|
||
|
|
Three Months Ended
|
||||||||||||||||||||||||||||||
|
|
April 1, 2017
|
|
March 26, 2016
|
||||||||||||||||||||||||||||
|
|
Probe Cards
|
|
Systems
|
|
Corporate and Other
|
|
Total
|
|
Probe Cards
|
|
Systems
|
|
Corporate and Other
|
|
Total
|
||||||||||||||||
|
Revenues
|
$
|
106,496
|
|
|
$
|
22,333
|
|
|
$
|
—
|
|
|
$
|
128,829
|
|
|
$
|
53,611
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
53,611
|
|
|
Gross profit
|
$
|
42,820
|
|
|
$
|
12,090
|
|
|
$
|
(7,339
|
)
|
|
$
|
47,571
|
|
|
$
|
12,509
|
|
|
$
|
—
|
|
|
$
|
(2,717
|
)
|
|
$
|
9,792
|
|
|
Gross margin
|
40.2
|
%
|
|
54.1
|
%
|
|
—
|
%
|
|
36.9
|
%
|
|
23.3
|
%
|
|
—
|
%
|
|
—
|
%
|
|
18.3
|
%
|
||||||||
|
Operating income (loss)
|
$
|
21,742
|
|
|
$
|
5,122
|
|
|
$
|
(19,805
|
)
|
|
$
|
7,059
|
|
|
$
|
(2,029
|
)
|
|
$
|
—
|
|
|
$
|
(11,544
|
)
|
|
$
|
(13,573
|
)
|
|
|
Three Months Ended
|
||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||
|
Revenues
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenues
|
63.1
|
|
|
81.7
|
|
|
Gross profit
|
36.9
|
|
|
18.3
|
|
|
Operating expenses:
|
|
|
|
||
|
Research and development
|
13.5
|
|
|
20.3
|
|
|
Selling, general and administrative
|
17.7
|
|
|
23.3
|
|
|
Restructuring and impairment charges, net
|
0.2
|
|
|
—
|
|
|
Total operating expenses
|
31.4
|
|
|
43.6
|
|
|
Operating income (loss)
|
5.5
|
|
|
(25.3
|
)
|
|
Interest income, net
|
—
|
|
|
0.2
|
|
|
Other income (expense), net
|
(1.2
|
)
|
|
(0.6
|
)
|
|
Income (loss) before income taxes
|
4.3
|
|
|
(25.7
|
)
|
|
Provision for income taxes
|
0.3
|
|
|
—
|
|
|
Net income (loss)
|
4.0
|
%
|
|
(25.7
|
)%
|
|
|
Three Months Ended
|
||||||
|
|
April 1, 2017
|
|
March 26, 2016
|
||||
|
|
(In thousands)
|
||||||
|
Probe Cards
|
$
|
106,496
|
|
|
$
|
53,611
|
|
|
Systems
|
22,333
|
|
|
—
|
|
||
|
Total
|
$
|
128,829
|
|
|
$
|
53,611
|
|
|
|
Three Months Ended
|
|||||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
|
% Change
|
|||||
|
|
(In thousands, except percentages)
|
|||||||||
|
Probe Cards Markets:
|
|
|
|
|
|
|||||
|
Foundry & Logic
|
$
|
74,310
|
|
|
$
|
36,135
|
|
|
105.6
|
%
|
|
DRAM
|
28,956
|
|
|
16,289
|
|
|
77.8
|
|
||
|
Flash
|
3,230
|
|
|
1,187
|
|
|
172.1
|
|
||
|
Systems Market:
|
|
|
|
|
|
|||||
|
Systems
|
22,333
|
|
|
—
|
|
|
100.0
|
|
||
|
Total revenues
|
$
|
128,829
|
|
|
$
|
53,611
|
|
|
140.3
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
|
April 1,
2017 |
|
% of
Revenue |
|
March 26,
2016 |
|
% of
Revenue |
||||||
|
|
(In thousands, except percentages)
|
||||||||||||
|
United States
|
$
|
39,841
|
|
|
30.9
|
%
|
|
$
|
17,555
|
|
|
32.7
|
%
|
|
Asia-Pacific (1)
|
26,006
|
|
|
20.2
|
|
|
3,595
|
|
|
6.7
|
|
||
|
Taiwan
|
19,545
|
|
|
15.2
|
|
|
12,660
|
|
|
23.6
|
|
||
|
South Korea
|
18,737
|
|
|
14.5
|
|
|
8,868
|
|
|
16.5
|
|
||
|
Japan
|
15,233
|
|
|
11.8
|
|
|
3,120
|
|
|
5.8
|
|
||
|
Europe
|
8,749
|
|
|
6.8
|
|
|
7,813
|
|
|
14.6
|
|
||
|
Rest of the world
|
718
|
|
|
0.6
|
|
|
—
|
|
|
—
|
|
||
|
Total revenues
|
$
|
128,829
|
|
|
100.0
|
%
|
|
$
|
53,611
|
|
|
100.0
|
%
|
|
(1)
|
Asia-Pacific includes all countries in the region except Taiwan, South Korea, and Japan, which are disclosed separately.
|
|
|
Three Months Ended
|
|
Three Months Ended
|
||||||||||||||||||||||||||||
|
|
April 1, 2017
|
|
March 26, 2016
|
||||||||||||||||||||||||||||
|
|
Probe Cards
|
|
Systems
|
|
Corporate and Other
|
|
Total
|
|
Probe Cards
|
|
Systems
|
|
Corporate and Other
|
|
Total
|
||||||||||||||||
|
Gross profit
|
$
|
42,820
|
|
|
$
|
12,090
|
|
|
$
|
(7,339
|
)
|
|
$
|
47,571
|
|
|
$
|
12,509
|
|
|
$
|
—
|
|
|
$
|
(2,717
|
)
|
|
$
|
9,792
|
|
|
Gross margin
|
40.2
|
%
|
|
54.1
|
%
|
|
—
|
|
|
36.9
|
%
|
|
23.3
|
%
|
|
—
|
%
|
|
—
|
|
|
18.3
|
%
|
||||||||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26, 2016
|
||||
|
|
|
||||||
|
Gross profit
|
$
|
47,571
|
|
|
$
|
9,792
|
|
|
Gross margin
|
36.9
|
%
|
|
18.3
|
%
|
||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
|
(In thousands, except percentages)
|
||||||
|
Research and development
|
$
|
17,414
|
|
|
$
|
10,849
|
|
|
% of revenues
|
13.5
|
%
|
|
20.3
|
%
|
||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
|
(In thousands, except percentages)
|
||||||
|
Selling, general and administrative
|
$
|
22,829
|
|
|
$
|
12,516
|
|
|
% of revenues
|
17.7
|
%
|
|
23.3
|
%
|
||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
|
(In thousands, except percentages)
|
||||||
|
Restructuring charges, net
|
$
|
269
|
|
|
$
|
—
|
|
|
% of revenues
|
0.2
|
%
|
|
—
|
%
|
||
|
|
Three Months Ended
|
||||||
|
|
April 1,
2017 |
|
March 26,
2016 |
||||
|
|
(In thousands, except percentages)
|
||||||
|
Interest income, net
|
$
|
67
|
|
|
$
|
117
|
|
|
% of revenue
|
—
|
%
|
|
0.2
|
%
|
||
|
Other income (expense), net
|
$
|
(1,574
|
)
|
|
$
|
(314
|
)
|
|
% of revenues
|
(1.2
|
)%
|
|
(0.6
|
)%
|
||
|
|
Three Months Ended
|
||||||
|
|
April 1, 2017
|
|
March 26, 2016
|
||||
|
|
(In thousands)
|
||||||
|
Net cash provided by (used in) operating activities
|
$
|
17,803
|
|
|
$
|
(3,032
|
)
|
|
Net cash (used in) provided by investing activities
|
(3,330
|
)
|
|
5,007
|
|
||
|
Net cash (used in) provided by financing activities
|
$
|
(2,651
|
)
|
|
$
|
1,961
|
|
|
Period (fiscal months)
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)
|
|
Maximum Amount that May Yet Be Purchased Under the Plans or Programs
|
||||||
|
January 1 2017-January 28, 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
25,000,000
|
|
|
January 29, 2017-February 25, 2017
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
25,000,000
|
|
|
|
February 26, 2017-April 1, 2017
|
|
250,000
|
|
|
10.92
|
|
|
250,000
|
|
|
$
|
22,270,000
|
|
|
|
|
|
250,000
|
|
|
$
|
10.92
|
|
|
250,000
|
|
|
|
||
|
Exhibit
|
|
|
|
Incorporated by Reference
|
|
Filed
|
||||
|
Number
|
|
Exhibit Description
|
|
Form
|
|
Date
|
|
Number
|
|
Herewith
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.01
|
|
Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.02
|
|
Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.01
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
|
|
|
|
FormFactor, Inc.
|
|
|
|
|
|
|
|
Date:
|
May 10, 2017
|
By:
|
/s/ Michael M. Ludwig
|
|
|
|
|
|
|
|
|
|
Michael M. Ludwig
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
(Duly Authorized Officer, Principal Financial Officer, and Principal Accounting Officer)
|
|
Exhibit
|
|
|
|
Incorporated by Reference
|
|
Filed
|
||||
|
Number
|
|
Exhibit Description
|
|
Form
|
|
Date
|
|
Number
|
|
Herewith
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.01
|
|
Certification of Chief Executive Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.02
|
|
Certification of Chief Financial Officer pursuant to 15 U.S.C. Section 7241, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.01
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|